SCHEMBL6595084

SCHEMBL6595084

COc1ccc(C(=O)Oc2ccc3oc(-c4oc(=O)c(C)c(OC(C)=O)c4C)cc3c2)cc1

nearest known ligand 0.47

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
GBA1 P04062 2/20 0.47
ALDH1A1 P00352 6/20 0.46
KMT2A Q03164 3/20 0.46
POLB P06746 1/20 0.46
F12 P00748 2/20 0.45
GAPDH P04406 3/20 0.45
KDM4E B2RXH2 5/20 0.42
MAPT P10636 3/20 0.42
MEN1 O00255 1/20 0.42
CYP2C9 P11712 2/20 0.42
CYP2C19 P33261 2/20 0.42
CA12 O43570 3/20 0.41
CA9 Q16790 3/20 0.41
FLT3 P36888 1/20 0.41
MAOB P27338 1/20 0.41
HPGD P15428 3/20 0.40
CA1 P00915 1/20 0.40
CA2 P00918 1/20 0.40
CA3 P07451 1/20 0.40
CA6 P23280 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6594235 0.91 CA9 (0.52) ALDH1A1KMT2APOLBGAPDHKDM4E
SCHEMBL6590922 0.91 KDM4E (0.51) ALDH1A1GAPDHKDM4EMAPTCYP2C9
SCHEMBL6594523 0.89 GAPDH (0.53) ALDH1A1KMT2APOLBGAPDHKDM4E
SCHEMBL6595025 0.85 MAOB (0.43) ALDH1A1POLBF12GAPDHKDM4E
SCHEMBL6592337 0.85 MAPT (0.50) GBA1ALDH1A1KMT2APOLBKDM4E
SCHEMBL6591799 0.85 POLB (0.46) ALDH1A1POLBF12GAPDHKDM4E
SCHEMBL6591205 0.82 TP53 (0.42) ALDH1A1GAPDHKDM4EMAPTCA12
SCHEMBL6590541 0.82 ALDH1A1 (0.51) ALDH1A1KMT2APOLBKDM4EMAPT
SCHEMBL6596557 0.80 MAOB (0.47) ALDH1A1GAPDHKDM4ECA12CA9
SCHEMBL6592169 0.80 KDM4E (0.53) GBA1ALDH1A1KMT2APOLBGAPDH

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1063235-B1 BENZOFURYLPYRONE DERIVATIVES TEIJIN LTD (JP) 2004-05-12 EP disclosed
US-20030186976-A1 Benzofurylpyrone derivatives TEIJIN LIMITED, MICROBIAL CHEMISTRY RESEARCH FOUNDATION 2003-10-02 US disclosed
US-6589984-B1 Blood cholesterol and triglycerides (TG) themselves are generally insoluble in blood, and they exist as lipoproteins by binding with apolipoproteins. In the body, triglycerides are biosynthesized primarily in the liver from acetyl CoA as TEIJIN LIMITED (JP) 2003-07-08 US disclosed
EP-1063235-A1 BENZOFURYLPYRONE DERIVATIVES TEIJIN LIMITED (JP) 2000-12-27 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20030186976-A1 Benzofurylpyrone derivatives PLIN5, ACSL5, PLIN1 GBA1 1766/4885ALDH1A1 1272/4885KMT2A 4009/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.